{
    "@graph": [
        {
            "@id": "gnd:4006890-0",
            "sameAs": "Biopharmazie"
        },
        {
            "@id": "gnd:4036943-2",
            "sameAs": "Magen"
        },
        {
            "@id": "gnd:4164223-5",
            "sameAs": "Klinisches Experiment"
        },
        {
            "@id": "gnd:4184308-3",
            "sameAs": "Tablette"
        },
        {
            "@id": "gnd:4326896-1",
            "sameAs": "Magenentleerung"
        },
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A799205621",
            "@type": "bibo:Thesis",
            "P1053": "Online-Ressource (PDF-Datei: 170 S., 17746 KB)",
            "creator": "Neumann, Marco",
            "description": "Ill., graph. Darst.",
            "identifier": [
                "(firstid)GBV:799205621",
                "(ppn)799205621"
            ],
            "publisher": "Universit√§tsbibliothek",
            "subject": [
                "(classificationName=ddc-dbn)610",
                "(classificationName=linseach:mapping)hor",
                "(classificationName=linseach:mapping)cet",
                "(classificationName=linseach:mapping)meda",
                "(classificationName=bk, id=181571781)44.41 - Pharmazeutische Biologie",
                "(classificationName=ddc-dbn)540",
                "(classificationName=linseach:mapping)bio",
                "(classificationName=bk, id=106417622)58.28 - Pharmazeutische Technologie"
            ],
            "title": "Entwicklung und Charakterisierung gastroretentiver Darreichungsformen",
            "abstract": [
                "Biopharmazie, Magen, Magenentleerung, Tablette, Klinisches Experiment, Gastroretention",
                "Prolonging the retention time of oral solid dosage forms in the stomach may be highly advantageous especially for drugs exhibiting absorption windows in the upper small intestine or showing low oral bioavailability. Concurrently, controlled drug delivery can avoid plasma peak levels and fluctuations in the plasma profile. The purpose of this thesis was the development and both, the in vitro and the in vivo characterization of gastroretentive dosage forms. The main part focussed on the development of a novel dosage form with reliable gastroretention for several hours in fasted as well as postprandial state while exhibiting controlled drug release in the stomach. The system consisted of a core tablet containing the active ingredient surrounded by a swellable coat tablet enabling intended gastroretention via expansion. Within the scope of drug formulation the combination of high and low molecular weight polyethylene oxide has proved to be suited for controlled drug release from the core tablet. Addition of water soluble, osmotically active excipients allowed almost pH-independent and complete drug delivery. In vitro swelling studies performed with the coat tablets demonstrated a fast, pronounced increase in size in simple dissolution media. In the second part of the thesis, a magnetic marker monitoring study (MMM) was conducted to analyze the gastroretentive potential of the new system containing the diuretic furosemide. The MMM technique is based on magnetic labelling of dosage ..."
            ],
            "contributor": "Technische Informationsbibliothek (TIB)",
            "isPartOf": "(collectioncode)GBV-ODiss",
            "issued": "2014",
            "language": "http://id.loc.gov/vocabulary/iso639-1/de",
            "license": "open access",
            "medium": "rda:termList/RDACarrierType/1018",
            "dcterms:subject": [
                {
                    "@id": "gnd:4184308-3"
                },
                {
                    "@id": "gnd:4164223-5"
                },
                {
                    "@id": "gnd:4036943-2"
                },
                {
                    "@id": "gnd:4326896-1"
                },
                {
                    "@id": "gnd:4006890-0"
                }
            ]
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "sameAs": "http://www.w3.org/2002/07/owl#sameAs",
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "publisher": "http://purl.org/dc/elements/1.1/publisher",
        "abstract": "http://purl.org/dc/terms/abstract",
        "license": "http://purl.org/dc/terms/license",
        "title": "http://purl.org/dc/elements/1.1/title",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "contributor": "http://purl.org/dc/terms/contributor",
        "description": "http://purl.org/dc/elements/1.1/description",
        "creator": "http://purl.org/dc/elements/1.1/creator",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "issued": "http://purl.org/dc/terms/issued",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}